XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia
عنوان الدراسة
XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia
داعم الدراسة
Bayer
دواء الدراسة
Rivaroxaban
رقم بروتوكول الدراسة
17237
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.